53 Prevalence of secondary prevention medication use in South America 2 Publication Study Design Study population Participation rate Participants characteristics Outcome Risk of bias Luz, 2005 1 1 0 1 1 4 Mansur, 2001 2 1 0 1 0 4 Meirelles, 2006 2 0 0 1 1 4 Missel, 2009 2 0 0 1 1 4 Moreno, 2011 2 0 1 0 1 4 Navar, 2019 1 1 1 0 1 4 Oliveira, 2004 1 1 0 1 1 4 Peressoni, 2004 2 0 0 1 1 4 Prado, 2015 1 0 0 2 1 4 Rahmi, 2019 2 0 2 0 0 4 Santos, 2019 2 1 0 1 0 4 Serrano, 2010 2 0 2 0 0 4 Silva, 2012 1 0 2 1 0 4 Silva, 2014 1 1 0 2 0 4 Taty Zau , 2018 1 0 0 2 1 4 Theme-Filha, 2005 1 2 0 1 0 4 Vicario, 2005 1 1 0 1 1 4 Cruz, 2012 0 0 1 1 1 3 Da Silva, 2020 1 0 0 2 0 3 Dantas, 2002 1 1 0 1 0 3 Kampits, 2016 1 1 0 1 0 3 Kampits, 2016 1 0 0 1 1 3 Stein, 2004 1 0 0 1 1 3 Villalobos, 2013 1 0 0 1 1 3 Duque, 2016 1 1 0 0 0 2 Eibel, 2017 1 0 0 1 0 2 Gagliardi, 2016 1 0 0 1 0 2 Gama, 2010 1 0 0 1 0 2 Gama, 2012 1 0 0 1 0 2 Castro, 2004 0 0 0 0 1 1 Note: Scoring: 0 points are attributed for high risk, 1 for moderate risk and 0 for high risk. Publications with a risk of bias score lower than 6 were not included in the review. Supplemtary File 3 B (Continued)
RkJQdWJsaXNoZXIy MTk4NDMw